Checkmate Pharmaceuticals
Biotechnology ResearchMassachusetts, United States11-50 Employees
Checkmate Pharmaceuticals is a clinical stage biopharmaceutical company focused upon activation of innate immunity to treat cancer.
Insights
Acquisition by Regeneron Checkmate Pharmaceuticals was acquired by Regeneron for $250M, presenting an opportunity to leverage Regeneron's resources and networks for potential collaboration or sales partnerships.
New Leadership Appointments Checkmate Pharma has recently appointed new key executives like Alan Bash as the President and CEO, signaling potential shifts in strategy and vision that could open doors for new business engagements.
Securities Law Issue Despite facing legal issues related to violating federal securities laws, Checkmate Pharma's situation presents an opportunity for legal services or compliance solutions providers to offer support and expertise.
Technology Stack As Checkmate Pharma employs a tech stack including Akamai and Node.js, technology companies specializing in complementary services or solutions could find opportunities to integrate their offerings with Checkmate's infrastructure.
Board of Directors Expansion With recent additions to Checkmate Pharma's Board of Directors like Jon Wigginton and Joy Yan, there may be opportunities for consulting firms or advisory services to engage with the company in strategic planning and governance areas.
Similar companies to Checkmate Pharmaceuticals
Scholar Rock
181
$10M$50MAthira Pharma
68$10M$50MDenali Therapeutics
422$50M$100MZentalis Pharmaceuticals
169$10M$50MSolid Biosciences
122$10M$50MKymera Therapeutics
204$10M$50MObsidian Therapeutics
112$10M$50MRejuvenate Bio
14$10MGemini Therapeutics
31Repligen Corporation
1.2K$100M$1B
Checkmate Pharmaceuticals Tech Stack
Checkmate Pharmaceuticals uses 8 technology products and services including Akamai, MySQL, Font Awesome, and more. Explore Checkmate Pharmaceuticals's tech stack below.
- AkamaiContent Delivery Network
- MySQLDatabase
- Font AwesomeFont Scripts
- jQuery MigrateJavascript Libraries
- SwiperJavascript Libraries
- Node.jsProgramming Languages
- Yoast SEOSearch Engines
- NginxWeb Servers
Media & News
Checkmate Pharmaceuticals's Email Address Formats
Checkmate Pharmaceuticals uses at least 1 format(s):
| Checkmate Pharmaceuticals Email Formats | Percentage |
| FLast@checkmatepharma.com | 50% |
| FLast@checkmatepharma.com | 50% |
Frequently Asked Questions
Where is Checkmate Pharmaceuticals's headquarters located?
Checkmate Pharmaceuticals's main headquarters is located at 245 Main St 2nd Floor Cambridge, Massachusetts 02142 US. The company has employees across 2 continents, including North AmericaAsia. What is Checkmate Pharmaceuticals's stock symbol?
Checkmate Pharmaceuticals is a publicly traded company; the company's stock symbol is CMPI. What is Checkmate Pharmaceuticals's official website and social media links?
Checkmate Pharmaceuticals's official website is checkmatepharma.com and has social profiles on LinkedIn.What is Checkmate Pharmaceuticals's SIC code NAICS code?
Checkmate Pharmaceuticals's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Checkmate Pharmaceuticals have currently?
As of May 2022, Checkmate Pharmaceuticals has approximately 35 employees across 2 continents, including North AmericaAsia. Key team members include Chief Operating Officer: K. B.Vice President, Quality: P. B.Senior Director: S. K.. Explore Checkmate Pharmaceuticals's employee directory with LeadIQ.What industry does Checkmate Pharmaceuticals belong to?
Checkmate Pharmaceuticals operates in the Biotechnology Research industry. What technology does Checkmate Pharmaceuticals use?
Checkmate Pharmaceuticals's tech stack includes AkamaiMySQLFont AwesomejQuery MigrateSwiperNode.jsYoast SEONginx. What is Checkmate Pharmaceuticals's email format?
Checkmate Pharmaceuticals's email format typically follows the pattern of . Find more Checkmate Pharmaceuticals email formats with LeadIQ. How much funding has Checkmate Pharmaceuticals raised to date?
As of May 2022, Checkmate Pharmaceuticals has raised $85M in funding. The last funding round occurred on Jun 10, 2020 for $85M.When was Checkmate Pharmaceuticals founded?
Checkmate Pharmaceuticals was founded in 2015.
Company Overview
- Headquarters
- 245 Main St 2nd Floor Cambridge, Massachusetts 02142 US
- Website
- checkmatepharma.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- Stock Symbol
- CMPI
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2015
- Employees
- 11-50
Media & News
Funding & Financials
- $85M
Checkmate Pharmaceuticals has raised a total of $85M of funding over 5 rounds. Their latest funding round was raised on Jun 10, 2020 in the amount of $85M.
Funding & Financials
- $85M
Checkmate Pharmaceuticals has raised a total of $85M of funding over 5 rounds. Their latest funding round was raised on Jun 10, 2020 in the amount of $85M.
Company Leadership
K. B.Chief Operating Officer
P. B.Vice President, Quality- S. K.Senior Director
C. K.Manager- C. C.Project Manager
Employee Directory
- H. L.Clinical Project Manager
- P. G.Manager, Cmc Project Management
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
